Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) fell 2% during trading on Tuesday . The company traded as low as $0.3350 and last traded at $0.3382. 187,031 shares were traded during trading, a decline of 100% from the average session volume of 62,169,492 shares. The stock had previously closed at $0.3450.
BioRestorative Therapies Price Performance
The company’s 50-day simple moving average is $0.33 and its two-hundred day simple moving average is $0.50. The firm has a market capitalization of $554.52 million, a P/E ratio of -0.32 and a beta of 102.36.
About BioRestorative Therapies
BioRestorative Therapies, Inc is a clinical‐stage regenerative medicine company focused on developing and commercializing advanced therapeutic platforms to promote tissue repair and healing. The company’s principal business activities are conducted through its wholly owned subsidiary, TissueForm, Inc, which holds the rights to a proprietary micro‐fiber scaffold technology designed to create a three‐dimensional matrix supporting cell migration, proliferation and new tissue formation. BioRestorative’s work is primarily targeted at chronic and non‐healing wounds, including diabetic foot ulcers and other complex soft‐tissue injuries.
The cornerstone of BioRestorative’s product pipeline is the TissueForm® line of scaffold materials.
See Also
- Five stocks we like better than BioRestorative Therapies
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
-plc-logo-1200x675.jpg){kind=logo}
